O36.8220 Fetal anemia and thrombocytopenia, second trimester, not applicable or unspecified

Name of the Condition

• Fetal anemia and thrombocytopenia, second trimester, not applicable or unspecified
• ICD-10 Code: O36.8220

Summary

This condition involves reduced red blood cell count (anemia) and low platelet levels (thrombocytopenia) in the fetus during the second trimester of pregnancy. It may require monitoring or intervention to assess fetal well-being and address potential complications.

Causes

Fetal anemia can result from maternal-fetal blood group incompatibility, inherited red blood cell disorders, or placental abnormalities. Thrombocytopenia may stem from immune-mediated processes, infections, or placental dysfunction. Both conditions can arise from underlying maternal or fetal factors affecting blood cell production or survival.

Risk Factors

• Maternal conditions such as autoimmune disorders or infections.
• Previous pregnancies with fetal blood disorders.
• Exposure to substances or medications affecting fetal hematopoiesis.
• Placental abnormalities or insufficiency.

Symptoms

Fetal symptoms are not directly observable, but prenatal care may reveal abnormal growth patterns, reduced fetal movement, or ultrasound findings indicative of anemia or thrombocytopenia. Maternal symptoms are typically absent unless complications arise.

Diagnosis

Diagnosis is made through prenatal ultrasound, Doppler flow studies to assess blood flow, and amniocentesis or cordocentesis to evaluate fetal blood counts. Maternal blood tests may also screen for underlying causes or immune factors.

Treatment Options

Management may include close monitoring, blood transfusions (in severe cases), or addressing underlying causes such as treating infections or managing maternal conditions. Interventions depend on the severity and specific clinical context.

Prognosis and Follow-Up

Prognosis varies based on the underlying cause and severity. Regular prenatal monitoring is essential to track fetal status and adjust care as needed. Follow-up may involve serial ultrasounds or additional testing to assess response to treatment.

Complications

Potential complications include fetal growth restriction, hydrops fetalis, or increased risk of bleeding. Severe cases may lead to preterm delivery or other adverse pregnancy outcomes.

Lifestyle & Prevention

While specific prevention may not be possible, maintaining regular prenatal care and addressing maternal health conditions can help mitigate risks. Avoiding known teratogens or substances affecting blood cell production is advisable.

When to Seek Professional Help

Seek medical attention if prenatal monitoring reveals abnormal findings, such as reduced fetal movement, abnormal growth, or concerning ultrasound results. Prompt evaluation is important for timely intervention.

Tips for Medical Coders

Document the trimester (second trimester) and specify if the condition is not applicable or unspecified. Ensure clinical documentation supports the diagnosis and aligns with the code’s specificity.